{"id":135629,"date":"2024-05-03T14:45:38","date_gmt":"2024-05-03T18:45:38","guid":{"rendered":"https:\/\/ccs.ca\/?page_id=135629"},"modified":"2024-05-21T14:10:10","modified_gmt":"2024-05-21T18:10:10","slug":"2024-ccs-bms-hypertrophic-cardiomyopathy-hcm-research-award","status":"publish","type":"page","link":"https:\/\/ccs.ca\/2024-ccs-bms-hypertrophic-cardiomyopathy-hcm-research-award\/","title":{"rendered":"2024 CCS-BMS HYPERTROPHIC CARDIOMYOPATHY (HCM) RESEARCH AWARD – Handbook"},"content":{"rendered":"\n
\n\n\n\n

The CCS Research Fellowships and Awards program was established to foster growth of peer-reviewed Canadian cardiovascular research and researchers. With support from like-minded organizations committed to empowering clinician scientists nationally, the CCS Research Fellowships and Awards program supports topics of research that span the various areas of cardiovascular medicine. The CCS, and all program partners, encourage all eligible CCS members to apply including underrepresented groups women and gender minorities, Indigenous Peoples, persons with disabilities, racialized individuals, and members of the 2SLGBTQIA+ communities.<\/p>\n\n\n\n

Please refer to Appendix A for CCS Terms and Conditions for all CCS Research and Fellowship Awards<\/a><\/p>\n\n\n\n

CONTACT<\/u><\/strong><\/h2>\n\n\n\n

For information regarding research programs, governing policies, and application submissions, please contact: Research and Fellowship Awards Email: researchawards@ccs.ca<\/a><\/p>\n\n\n\n

DEADLINE<\/u><\/strong><\/h2>\n\n\n\n

Application submissions must be made online through the CCS On-line submission platform<\/a>. CCS offers a secure internet portal which allows the applicant to electronically submit grant applications. All application submissions are due online on Cadmium by May 7, 2024.  Additional time allowances will not usually be granted for any reason. Notices of Decision will be shared in mid-July 2024. Funding is projected to be disbursed starting in fall 2024.<\/p>\n\n\n\n

FUNDING OPPORTUNITY<\/u><\/strong><\/h2>\n\n\n\n

The Canadian Cardiovascular Society and Bristol Myers Squibb (BMS) are proud to support the CCS-BMS Hypertrophic Cardiomyopathy (HCM) Research Award. The purpose of this award is to foster growth of peer-reviewed Canadian research in the area of HCM, with a focus on HCM diagnosis, progression, monitoring, epidemiology and \/ or prevalence.<\/p>\n\n\n\n

OBJECTIVE<\/span><\/strong><\/h2>\n\n\n\n

The objective of the Hypertrophic Cardiomyopathy (HCM) Research Award is:<\/p>\n\n\n\n